Next Article in Journal
Design and Synthesis of Bis-amide and Hydrazide-containing Derivatives of Malonic Acid as Potential HIV-1 Integrase Inhibitors
Previous Article in Journal
Characterization of Hydrocortisone Biometabolites and 18S rRNA Gene in Chlamydomonas reinhardtii Cultures
Open AccessArticle

Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly

1
School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, P.R. China
2
The National Center for Drug Screening, Chinese Academy of Sciences, Shanghai 201203, P.R. China
3
School of Biotechnology, Southwest University, Chongqing 400715, P.R. China
4
Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P.R. China
*
Authors to whom correspondence should be addressed.
Molecules 2008, 13(10), 2426-2441; https://doi.org/10.3390/molecules13102426
Received: 30 September 2008 / Revised: 18 September 2008 / Accepted: 18 September 2008 / Published: 1 October 2008
CCR5, as the major co-receptor for HIV-1 entry, is an attractive novel target for the pharmaceutical industry in the HIV-1 therapeutic area. In this study, based on the structures of maraviroc and 1,4-bis(4-(7-chloroquinolin-4-yl)piperazin-1-yl)butane-1,4-dione (1), which was identified using structure-based virtual screening in conjunction with a calcium mobilization assay, a series of novel small molecule CCR5 antagonists have been designed and synthesized through fragment assembly. Preliminary SARs were obtained, which are in good agreement with the molecular binding model and should prove helpful for future antagonist design. The novel scaffold presented here might also be useful in the development of maraviroc-derived second generation CCR5 antagonists. View Full-Text
Keywords: CCR5 antagonist; fragment assembly; HIV-1; molecular modeling CCR5 antagonist; fragment assembly; HIV-1; molecular modeling
Show Figures

Graphical abstract

MDPI and ACS Style

Liu, Y.; Zhou, E.; Yu, K.; Zhu, J.; Zhang, Y.; Xie, X.; Li, J.; Jiang, H. Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly. Molecules 2008, 13, 2426-2441. https://doi.org/10.3390/molecules13102426

AMA Style

Liu Y, Zhou E, Yu K, Zhu J, Zhang Y, Xie X, Li J, Jiang H. Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly. Molecules. 2008; 13(10):2426-2441. https://doi.org/10.3390/molecules13102426

Chicago/Turabian Style

Liu, Yanqing; Zhou, Enkun; Yu, Kunqian; Zhu, Jin; Zhang, Yu; Xie, Xin; Li, Jian; Jiang, Hualiang. 2008. "Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly" Molecules 13, no. 10: 2426-2441. https://doi.org/10.3390/molecules13102426

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop